Dhruv Kaushal has more than a decade of experience serving as strategic counsel to life sciences clients in patent matters and technology transactions. Drawing on a diverse background in private practice and as a research scientist, in-house legal counsel and a member of the founding team of a cell therapy startup, Dhruv helps clients understand and manage the full scope of intellectual property-driven challenges facing their businesses.
Clients ranging from small biotech startups to Fortune 500 companies look to Dhruv as a thought partner in protecting innovations, managing third-party intellectual property risk and facilitating transactions involving intellectual property assets. His practice encompasses patent preparation and prosecution, patent portfolio management, analyses of patent scope and validity, patent landscapes and white-space, new product clearance and preparation of formal opinions of counsel on invalidity or noninfringement, negotiation and drafting of licenses and other IP-focused commercial agreements, providing IP support for M&A and financing transactions, and post-grant patent proceedings before the USPTO.
As a former in-house patent attorney, Dhruv is experienced in tailoring legal services to address specific business challenges and in translating legal work product into actionable information for stakeholders at all levels of client organizations. He leverages his operating experience to help clients execute on their IP strategies through services including patent portfolio audits and patent quality assessments, IP activity roadmaps for R&D enterprises, and implementing and owning client-side processes for management of patent assets and third-party patent risk.
Prior to joining Armstrong Teasdale, Dhruv was a principal at a boutique IP law firm in Boston and a member of the founding team of a stealth-phase cell therapy company, where he supported strategic planning and organizational development matters and led the company’s licensing and IP efforts.
Earlier in his career, Dhruv served as in-house patent counsel for a leading gene editing company developing first-in-class CRISPR medicines. While there he built and led a multimillion-dollar annual patent protection and analysis function comprising internal and external professionals, served as liaison to academic licensors and development partners on IP matters, delivered strategic advice to the company’s senior leadership and supported the company’s therapeutic development programs.
- Boston University School of Law (J.D.)
- American Journal of Law and Medicine (Editorial Staff Member)
- University of California, San Diego (Ph.D.)
- National Science Foundation Fellowship
- PhRMA Foundation Fellowship
- Co-authored nine peer reviewed journal articles
- University of New Mexico (B.S., magna cum laude)
- Full academic scholarship
- U.S. Patent and Trademark Office
Charitable and Civic Involvement
- Town of Sherborn Advisory Committee, Sherborn, Mass. (Member)
- American Cancer Society Postdoctoral Fellowship